Persperion Diagnostics Overview
- Year Founded
-
2022
- Status
-
Private
- Employees
-
13
- Latest Deal Type
-
Early Stage VC
- Latest Deal Amount
-
$450K
- Investors
-
9
Persperion Diagnostics General Information
Description
Operator of a medical device company intended to develop a novel non-invasive sweat biomarker sensing technology. The company aims to reimagine personalized health management using natural fingertip sweat and develops a touch-based enzymatic electrochemical sensing strip, enabling patients to sense different biomarkers within natural fingertip perspiration.
Contact Information
Website
persperion.comCorporate Office
- 7916 Convoy Court
- San Diego, CA 92111
- United States
Corporate Office
- 7916 Convoy Court
- San Diego, CA 92111
- United States
Persperion Diagnostics Timeline
Persperion Diagnostics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Early Stage VC | 29-May-2025 | $450K | Completed | Generating Revenue | ||
| 4. Accelerator/Incubator | 08-Apr-2024 | Completed | Generating Revenue | |||
| 3. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 2. Seed Round | 08-Jun-2023 | $4M | $4M | Completed | Generating Revenue | |
| 1. University Spin-Out | 01-Jan-2022 | Completed | Generating Revenue |
Persperion Diagnostics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Persperion Diagnostics Patents
Persperion Diagnostics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2024289908-A1 | Touch-based biomarker monitoring system | Pending | 06-Jul-2023 | ||
| EP-4739205-A1 | Touch-based biomarker monitoring system | Pending | 06-Jul-2023 | ||
| US-20250241583-A1 | Touch-based biomarker monitoring system | Pending | 06-Jul-2023 | ||
| WO-2025010373-A1 | Touch-based biomarker monitoring system | Inactive | 06-Jul-2023 | A61B5/4266 |
Persperion Diagnostics Signals
Persperion Diagnostics Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Cornucopian Capital | Venture Capital | Minority | ||
| Linear Capital | Venture Capital | Minority | ||
| Miracleplus | Accelerator/Incubator | |||
| Samsung NEXT Ventures | Corporate Venture Capital | Minority | ||
| CONNECT (San Diego) | Accelerator/Incubator |
Persperion Diagnostics FAQs
-
When was Persperion Diagnostics founded?
Persperion Diagnostics was founded in 2022.
-
Where is Persperion Diagnostics headquartered?
Persperion Diagnostics is headquartered in San Diego, CA.
-
What is the size of Persperion Diagnostics?
Persperion Diagnostics has 13 total employees.
-
What industry is Persperion Diagnostics in?
Persperion Diagnostics’s primary industry is Diagnostic Equipment.
-
Is Persperion Diagnostics a private or public company?
Persperion Diagnostics is a Private company.
-
What is Persperion Diagnostics’s current revenue?
The current revenue for Persperion Diagnostics is .
-
How much funding has Persperion Diagnostics raised over time?
Persperion Diagnostics has raised $4.45M.
-
Who are Persperion Diagnostics’s investors?
Cornucopian Capital, Linear Capital, Miracleplus, Samsung NEXT Ventures, and CONNECT (San Diego) are 5 of 9 investors who have invested in Persperion Diagnostics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process